Cleared Traditional

K043108 - LIQUICHEK SPECIALTY IMMUNOASSAY CONTROL

K043108 is the FDA 510(k) clearance for LIQUICHEK SPECIALTY IMMUNOASSAY CONTROL by Bio-Rad Laboratories, Inc.. It is a Class 1 Immunology device (product code JJY) cleared through the Traditional 510(k) pathway after a 28-day FDA review.

K043108 · Bio-Rad Laboratories, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2004
Decision
28d
Days
Class 1
Risk

K043108 is an FDA 510(k) clearance for the LIQUICHEK SPECIALTY IMMUNOASSAY CONTROL. Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.

Submitted by Bio-Rad Laboratories, Inc. (Irvine, US). The FDA issued a Cleared decision on December 7, 2004 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.1660 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bio-Rad Laboratories, Inc. devices

Submission Details

510(k) Number K043108 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 09, 2004
Decision Date December 07, 2004
Days to Decision 28 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
76d faster than avg
Panel avg: 104d · This submission: 28d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJY Multi-analyte Controls, All Kinds (assayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJY Multi-analyte Controls, All Kinds (assayed)

All 342
Devices cleared under the same product code (JJY) and FDA review panel - the closest regulatory comparables to K043108.
ROCHE DIAGNOSTICS ELECSYS PRECICONTROL TUMOR
K050387 · Roche Diagnostics Corp. · Apr 2005
QUEST DIAGNOSTICS IMMUNOASSAY/TDM CONTROL
K050536 · Bio-Rad · Mar 2005
LIQUID ASSAYED MULTIQUAL CONTROL
K043208 · Bio-Rad · Jan 2005
QUEST TUMOR MARKER CONTROL, MODEL 955
K042815 · Bio-Rad · Nov 2004
LYPHOCHEK ELEVATED IMMUNOSUPPRESSANT CONTROL, LEVEL 4, 5
K042324 · Bio-Rad · Oct 2004
ARCHITECT FREE PSA MASTERCHECK, MODEL 6C07-05
K042335 · Bio-Rad Laboratories, Inc. · Sep 2004